Fig. 1From: Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosisOverview of the study populations and schematic proteomic workflow. The CSF of cohorts comprising MS and control subjects was analyzed. The total number of subjects per cohort group is depicted. Dark and light shades represent female and male subjects, respectivelyBack to article page